Top

Current Behavioral Neuroscience Reports

Published in:

01-09-2019 | Schizophrenia | Psychosis (A Ahmed, Section Editor)

Neuroplasticity and Cognitive Training in Schizophrenia

Authors: Sujita Kumar Kar, Amit Singh

Published in: Current Behavioral Neuroscience Reports | Issue 3/2019

Abstract

Purpose of Review

This review attempts to link cognitive training with neuroplasticity in schizophrenia evaluating the research evidences.

Recent Findings

Schizophrenia is a severe mental disorder that often follows a chronic course and affects multiple domains of functioning. Cognitive deficits in schizophrenia are one of the commonest causes of the functional impairments. Alterations in neuroplasticity in schizophrenia may be directly linked to the cognitive deficits in schizophrenia. The cognitive deficits in schizophrenia can be improved with specific cognitive remediation techniques. Over the past few decades, much emphasis has been given in targeting the cognitive deficits to improve the functional outcomes in schizophrenia.

Summary

Cognitive remediation techniques have been effective in improving various domains of cognition as well as having a neuroplastic effect. The neuroplastic effect of cognitive remediation has been further augmented after addition of certain augmenting procedures (example: transcranial direct current stimulation) in schizophrenia as found in recent researches.

Schverer M, Lanfumey L, Baulieu E-E, Froger N, Villey I. Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases. Pharmacol Ther [Internet]. 2018 [cited 2019 Feb 27];191:190–206. Available from: http://www.sciencedirect.com/science/article/pii/S016372581830113X. Accessed 27 Feb 2019.

• Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A. Neuroplasticity: changes in grey matter induced by training. Nature. 2004;427(6972):311–2 This article supports structural changes in brain in response to training.CrossRefPubMed

Cramer SC, Sur M, Dobkin BH, O’Brien C, Sanger TD, Trojanowski JQ, et al. Harnessing neuroplasticity for clinical applications. Brain [Internet]. 2011 [cited 2019 Feb 28];134(6):1591–609. Available from: https://academic.oup.com/brain/article/134/6/1591/369496. Accessed 28 Feb 2019.

Pittenger C, Duman RS. Stress, Depression, and Neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology [Internet]. 2008 [cited 2019 Mar 1];33(1):88–109. Available from: https://www.nature.com/articles/1301574. Accessed 01 March 2019.

• Vance DE, Roberson AJ, McGuinness TM, Fazeli PL. How neuroplasticity and cognitive reserve protect cognitive functioning. J Psychosoc Nurs Ment Health Serv. 2010 Apr; 48(4):23–30. https://doi.org/10.3928/02793695-20100302-01. This article discusses about various types of neuroplasticity and their relevance in cognitive functioning.

Nicoll RA. A brief history of long-term potentiation. Neuron. 2017;93(2):281–90.CrossRefPubMed

Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004. 30;44(1):5–21. Available from: https://www.cell.com/neuron/abstract/S0896-6273(04)00608-7. Accessed 28 March 2019.

Yang Y, Calakos N. Presynaptic long-term plasticity. Front Synaptic Neurosci [Internet]. 2013 Oct 17 [cited 2019 May 23];5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797957/.Accessed 23 May 2019.

Knudsen EI. Sensitive periods in the development of the brain and behavior. J Cogn Neurosci. 2004 Oct;16(8):1412–25.

10.

Voss P, Thomas ME, Guercio GD, de Villers-Sidani E. Dysregulation of auditory neuroplasticity in schizophrenia. Schizophr Res. 2018

11.

Tien N-W, Kerschensteiner D. Homeostatic plasticity in neural development. Neural Dev [Internet]. 2018 [cited 2019 Mar 28];13(1):9. Available from: https://doi.org/10.1186/s13064-018-0105-x.Accessed 28 March 2019.

12.

Wilkinson ST, Holtzheimer PE, Gao S, Kirwin DS, Price RB. Leveraging neuroplasticity to enhance adaptive learning: the potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression. Biol Psychiatry [Internet]. 2019 Mar 15 [cited 2019 Feb 27];85(6):454–65. Available from: http://www.sciencedirect.com/science/article/pii/S0006322318318468. Accessed 27 Feb 2019.

13.

• Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity — exercise-induced response of peripheral brain-derived neurotrophic factor. Sports Med [Internet]. 2010 [cited 2019 Mar 29];40(9):765–801. Available from: https://doi.org/10.2165/11534530-000000000-00000. Accessed 29 March 2019. This systematic review supports the role of exercise in neuroplasticity, which is predominantly mediated through brain derived neurotrophic factor.

14.

Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70(5):271–88.PubMedPubMedCentral

15.

Hempstead BL. Brain-derived neurotrophic factor: three ligands, many actions. Trans Am Clin Climatol Assoc. 2015;126:9–19.PubMedPubMedCentral

16.

Orefice LL, Shih C-C, Xu H, Waterhouse EG, Xu B. Control of spine maturation and pruning through ProBDNF synthesized and released in dendrites. Mol Cell Neurosci. 2016;71:66–79.CrossRefPubMed

17.

Adachi N, Numakawa T, Richards M, Nakajima S, Kunugi H. New insight in expression, transport, and secretion of brain-derived neurotrophic factor: implications in brain-related diseases. World J Biol Chem. 2014;5(4):409–28.CrossRefPubMedPubMedCentral

18.

Sale MV, Ridding MC, Nordstrom MA. Cortisol inhibits neuroplasticity induction in human motor cortex. J Neurosci [Internet]. 2008 [cited 2019 Mar 29];28(33):8285–93. Available from: http://www.jneurosci.org/content/28/33/8285. Accessed 29 March 2019.

19.

• Barha CK, Galea LAM. Influence of different estrogens on neuroplasticity and cognition in the hippocampus. Biochim Biophys Acta Gen Subj [Internet]. 2010 [cited 2019 Mar 29];1800(10):1056–67. Available from: http://www.sciencedirect.com/science/article/pii/S0304416510000115. Accessed 29 March 2019. This article supports the possible role of gonadal hormones in neuroplasticity.

20.

Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry [Internet]. 2002 [cited 2019 Feb 27];59(6):553–8. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/206472. Accessed 27 Feb 2019.

21.

McCullumsmith RE. Evidence for schizophrenia as a disorder of neuroplasticity. Am J Psychiatry. 2015;172(4):312–3.CrossRefPubMed

22.

McCleery A, Wynn JK, Mathalon DH, Roach BJ, Green MF. Hallucinations, neuroplasticity, and prediction errors in schizophrenia. Scand J Psychol. 2018;59(1):41–8.CrossRefPubMedPubMedCentral

23.

De Picker LJ, Morrens M, Chance SA, Boche D. Microglia and brain plasticity in acute psychosis and schizophrenia illness course: a meta-review. Front Psychiatry. 2017;8:238.CrossRefPubMedPubMedCentral

24.

Kar SK, Jain M. Current understandings about cognition and the neurobiological correlates in schizophrenia. J Neurosci Rural Pract [Internet]. 2016 [cited 2018 Nov 23];7(3):412–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898111/. Accessed 23 Feb 2019.

25.

•• Tripathi A, Kar SK, Shukla R. Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies. Clin Psychopharmacol Neurosci. 2018;16(1):7–17 This review article elaborates about the pattern of cognitive deficits in schizophrenia along with their neural correlates and role of cognitive remediation strategies to deal with them. CrossRefPubMedPubMedCentral

26.

Spangaro M, Bosia M, Bechi M, Buonocore M, Cocchi F, Guglielmino C, et al. Neurobiology of cognitive remediation in schizophrenia: effects of EAAT2 polymorphism. Schizophr Res. 2018;202:106–10.CrossRefPubMed

27.

Rodrigues-Amorim D, Rivera-Baltanás T, Bessa J, Sousa N, Vallejo-Curto M de C, Rodríguez-Jamardo C, et al. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: a meta-analysis. J Psychiatr Res. 2018;106:43–53.CrossRefPubMed

28.

Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry [Internet]. 2011 [cited 2019 May 14];16(9):960–72. Available from: https://www.nature.com/articles/mp201088. Accessed 20 March 2019.

29.

Zhang XY, Liang J, Chen DC, Xiu MH, De Yang F, Kosten TA, et al. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology [Internet]. 2012 [cited 2019 May 14];222(2):277–84. Available from: https://doi.org/10.1007/s00213-012-2643-y. Accessed 23 March 2018.

30.

Jain M, Singh S, Dalal PK, Nischal A, Tripathi A, Kar SK. A cross-sectional study of cognitive functions and disability in schizophrenia from a tertiary care hospital in North India. Med J Dr DY Patil Univ [Internet]. 2016 [cited 2018 Nov 23];9(4):457. Available from: http://www.mjdrdypu.org/article.asp?issn=0975-2870;year=2016;volume=9;issue=4;spage=457;epage=464;aulast=Jain;type=0. Accessed 23 Feb 2019.

31.

Saperstein AM, Kurtz MM. Current trends in the empirical study of cognitive remediation for schizophrenia. Can J Psychiatr. 2013;58(6):311–8.CrossRef

32.

Barlati S, Deste G, Galluzzo A, Perin AP, Valsecchi P, Turrina C, et al. Factors associated with response and resistance to cognitive remediation in schizophrenia: a critical review. Front Pharmacol [Internet]. 2019 [cited 2019 Mar 21];9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335346/. Accessed 21 March 2019.

33.

Lindenmayer J-P, Ozog VA, Khan A, Ljuri I, Fregenti S, McGurk SR. Predictors of response to cognitive remediation in service recipients with severe mental illness. Psychiatr Rehabil J. 2017;40(1):61–9.CrossRefPubMed

34.

•• Vita A, Deste G, De Peri L, Barlati S, Poli R, Cesana BM, et al. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia. Schizophr Res. 2013;150(1):51–7 This review article emphasizes on exploring various neurobiological, cognitive, functional as well as phenomenological determinants of effectiveness of cognitive remediation therapy in schizophrenia.CrossRefPubMed

35.

Best MW, Bowie CR. A review of cognitive remediation approaches for schizophrenia: from top-down to bottom-up, brain training to psychotherapy. Expert Rev Neurother. 2017;17(7):713–23.CrossRefPubMed

36.

Campos C, Rocha NBF, Lattari E, Nardi AE, Machado S. Exercise induced neuroplasticity to enhance therapeutic outcomes of cognitive remediation in schizophrenia: analyzing the role of brain derived neurotrophic factor. CNS Neurol Disord Drug Targets. 2017;16(6):638–51.CrossRefPubMed

37.

Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry [Internet]. 2009 [cited 2019 May 14];66(6):549–53. Available from: http://www.sciencedirect.com/science/article/pii/S0006322309002303. Accessed 17 May 2019.

38.

Fisher M, Mellon SH, Wolkowitz O, Vinogradov S. Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophrenia Research: Cognition [Internet]. 2016 [cited 2019 May 14];3:1–7. Available from: http://www.sciencedirect.com/science/article/pii/S2215001315300068. Accessed 20 March 2019.

39.

Mandelman SD, Grigorenko EL. BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association. Genes Brain Behav. 2012;11(2):127–36.CrossRefPubMed

40.

Ahmed AO, Mantini AM, Fridberg DJ, Buckley PF. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis. Psychiatry Res. 2015;226(1):1–13.CrossRefPubMed

41.

Dondé C, Mondino M, Brunelin J, Haesebaert F. Sensory-targeted cognitive training for schizophrenia. Exp Rev Neurotherapeutics [Internet]. 2019 [cited 2019 Mar 28];19(3):211–25. Available from: https://doi.org/10.1080/14737175.2019.1581609. Accessed 29 March 2019

42.

Penadés R, Pujol N, Catalán R, Massana G, Rametti G, García-Rizo C, et al. Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 2013;73(10):1015–23.CrossRefPubMed

43.

•• Isaac C, Januel D. Neural correlates of cognitive improvements following cognitive remediation in schizophrenia: a systematic review of randomized trials. Socioaffect Neurosci Psychol [Internet]. 2016 [cited 2019 Mar 21];6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799394/. Accessed Feb 2019. This systematic review of randomized control trials has revealed that cognitive remediation targeting neuro-cognition and social cognition have neuro-plastic effect.

44.

Ramsay IS, MacDonald AW. Brain Correlates of Cognitive Remediation in Schizophrenia: Activation Likelihood Analysis Shows Preliminary Evidence of Neural Target Engagement. Schizophr Bull [Internet]. 2015 [cited 2019 May 14];41(6):1276–84. Available from: https://academic.oup.com/schizophreniabulletin/article/41/6/1276/2526026. Accessed 23 March 2019.

45.

Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Yamashita F, et al. Role of frontal white matter and corpus callosum on social function in schizophrenia. Schizophr Res [Internet]. 2018 [cited 2019 May 14];202:180–7. Available from: http://www.sciencedirect.com/science/article/pii/S0920996418304249. Accessed 23 Feb 2019.

46.

Habel U, Koch K, Kellermann T, Reske M, Frommann N, Wölwer W, et al. Training of affect recognition in schizophrenia: neurobiological correlates. Social Neurosci [Internet]. 2010 [cited 2019 May 14];5(1):92–104. Available from: https://doi.org/10.1080/17470910903170269. Accessed 20 March 2019.

47.

Adolphs R. The Social brain: neural basis of social knowledge. Annu Rev Psychol [Internet]. 2009 [cited 2019 May 14];60:693–716. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588649/. Accessed 23 Feb 2019.

48.

Benedetti F, Bernasconi A, Bosia M, Cavallaro R, Dallaspezia S, Falini A, et al. Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia. Schizophr Res. 2009;114(1–3):154–60.CrossRefPubMed

49.

•• Campos C, Santos S, Gagen E, Machado S, Rocha S, Kurtz MM, et al. Neuroplastic changes following social cognition training in schizophrenia: a systematic review. Neuropsychol Rev. 2016;26(3):310–28 This systematic review reports that social cognition training produces structural and functional changes in specific brain areas associated with social cognitive performance.CrossRefPubMed

50.

Falkai P, Malchow B, Schmitt A. Aerobic exercise and its effects on cognition in schizophrenia. Curr Opin Psychiatry. 2017;30(3):171–5.CrossRefPubMed

51.

• Jahshan C, Rassovsky Y, Green MF. Enhancing neuroplasticity to augment cognitive remediation in schizophrenia. Front Psychiatry. 2017;8:191 This review highlights the relevance of neuro-stimulation techniques like tDCS in augmenting the neuroplasticity when combined with cognitive remediation. CrossRefPubMedPubMedCentral

52.

Panatier A, Theodosis DT, Mothet J-P, Touquet B, Pollegioni L, Poulain DA, et al. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell. 2006;125(4):775–84.CrossRefPubMed

53.

Kantrowitz JT, Epstein ML, Beggel O, Rohrig S, Lehrfeld JM, Revheim N, et al. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. Brain. 2016;139(12):3281–95.CrossRefPubMedPubMedCentral

54.

Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, et al. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res. 2007;90(1–3):41–51.CrossRefPubMed

55.

Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindström LH, Iyo M. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2005;29(5):767–9.CrossRef

56.

Kantrowitz JT, Swerdlow NR, Dunn W, Vinogradov S. Auditory system target engagement during plasticity-based interventions in schizophrenia: a focus on modulation of N-methyl-D-aspartate–type glutamate receptor function. Biol Psychiatry. 2018;3(7):581–90.

57.

John AP, Yeak K, Ayres H, Dragovic M. Successful implementation of a cognitive remediation program in everyday clinical practice for individuals living with schizophrenia. Psychiatr Rehabil J. 2017;40(1):87–93.CrossRefPubMed

58.

Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology. 2012;37(1):43–76.CrossRefPubMed

59.

Guercio GD, Thomas ME, Cisneros-Franco JM, Voss P, Panizzutti R, de Villers-Sidani E. Improving cognitive training for schizophrenia using neuroplasticity enhancers: lessons from decades of basic and clinical research. Schizophr Res. 2018.

Title: Neuroplasticity and Cognitive Training in Schizophrenia
Authors: Sujita Kumar Kar
Amit Singh
Publication date: 01-09-2019
Publisher: Springer International Publishing
Keyword: Schizophrenia
Published in: Current Behavioral Neuroscience Reports / Issue 3/2019
Electronic ISSN: 2196-2979
DOI: https://doi.org/10.1007/s40473-019-00178-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neuroplasticity and Cognitive Training in Schizophrenia

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2019

Gradient Theories of Brain Activation: a Novel Application to Studying the Parental Brain

Linking Late Life Depression and Alzheimer’s Disease: Mechanisms and Resilience

Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics

Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease

Examining Neural Reactivity to Gambling Cues in the Age of Online Betting